Lion-owned Furphy has launched its second beer Furphy Crisp Lager, a 4.5% abv beer that’s “light, crisp and offers the ultimate refreshment” according to Little Creatures brewers.
Lion
Positioning hard seltzers as brewery ranges evolve
As beer evolves and breweries branch out into everything from kombucha to hard seltzers and RTDs, the question of how to integrate branding with your core range has come to the fore. Designer Tyson Sheean weighs in on the trend.
Lion “Australia’s first” large-scale carbon neutral brewer
Brewer Lion has announced that it has become Australia’s first large-scale carbon neutral brewer, and is close to achieving targets which will see it reduce its carbon footprint by 30 per cent by 2025.
Lion brings kegs to the NT
Following the Northern Territory’s announcement that venues will re-open on 15th May, XXXX Gold brewer Lion has ensured a keg convoy carrying 75,000 litres of draught beer will make its way to the NT over the next week.
Watchdog condemns big business payment terms
The Australian Small Business and Family Enterprise Ombudsman has criticised the payment terms of big businesses saying that they are “damaging” to small suppliers.
Lion backs venues after mandatory closures
Lion will take back untapped kegs from venues and refund the cost, as the big brewers attempt to help venues navigate the COVID-19 pandemic.
Dry launch comes amidst challenges for XXXX
The latest data from global big data and consumer insights specialist IRI Worldwide highlights the the pressure on Lion’s new XXXX Dry to resurrect the struggling brand’s fortunes.
Brews News Week #260 Malt Bae
On the Brews News Week podcast, we look at some interesting trials that could allow brewers to reuse their byproducts and the COVID-19 virus causes the IBD convention to be postponed.
Lion launches XXXX Dry
Lion has responded to declining sales across its XXXX brand range by launching a dry variant to tap into a new generation of drinkers.
Struggle over focus at Lion owners Kirin
Lion’s owners Kirin have doubled down on their pharma and food focus, despite earnings and profit declines in their Australia-based business.